64 related articles for article (PubMed ID: 2493336)
21. Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis.
Kemp CJ; Burns PA; Brown K; Nagase H; Balmain A
Cold Spring Harb Symp Quant Biol; 1994; 59():427-34. PubMed ID: 7587097
[No Abstract] [Full Text] [Related]
22. Two-stage tumorigenesis of dermal melanocytes in the back skin of the Syrian golden hamster using systemic initiation with 7,12-dimethylbenz(a)anthracene and topical promotion with 12-O-tetradecanoylphorbol-13-acetate.
Goerttler K; Loehrke H; Schweizer J; Hesse B
Cancer Res; 1980 Jan; 40(1):155-61. PubMed ID: 6765915
[No Abstract] [Full Text] [Related]
23. Initiation of skin carcinogenesis can occur by induction of carcinogen-specific point mutations in the Harvey-ras gene.
Bailleul B; Brown K; Ramsden M; Fee F; Balmain A
Prog Clin Biol Res; 1989; 298():137-45. PubMed ID: 2664807
[No Abstract] [Full Text] [Related]
24. Molecular and cellular basis for tumor promotion in mouse skin.
Yuspa SH
Princess Takamatsu Symp; 1983; 14():315-26. PubMed ID: 6394593
[TBL] [Abstract][Full Text] [Related]
25. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice.
Suganuma M; Okabe S; Marino MW; Sakai A; Sueoka E; Fujiki H
Cancer Res; 1999 Sep; 59(18):4516-8. PubMed ID: 10493498
[TBL] [Abstract][Full Text] [Related]
26. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.
Malliri A; van der Kammen RA; Clark K; van der Valk M; Michiels F; Collard JG
Nature; 2002 Jun; 417(6891):867-71. PubMed ID: 12075356
[TBL] [Abstract][Full Text] [Related]
27. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
O'Brien TG; Megosh LC; Gilliard G; Soler AP
Cancer Res; 1997 Jul; 57(13):2630-7. PubMed ID: 9205069
[TBL] [Abstract][Full Text] [Related]
28. [Activation of oncogenes by chemical modification with carcinogens].
Hashimoto Y; Shudo K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3354-64. PubMed ID: 3098180
[TBL] [Abstract][Full Text] [Related]
29. Increased tumour incidence and skin tumour promotion in two generations of descendants of 7,12-dimethylbenz[a]anthracene-treated pregnant mice.
Likhachev A; Anisimov V; Loktionov A; Zabezhinski M; Napalkov N; Tomatis L
IARC Sci Publ; 1989; (96):81-92. PubMed ID: 2509350
[TBL] [Abstract][Full Text] [Related]
30. Initiation and promotion in young and old animals. Implications for human tumour formation.
Stenbäck F; Arranto A
IARC Sci Publ; 1985; (58):151-66. PubMed ID: 3938448
[TBL] [Abstract][Full Text] [Related]
31. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
33. On the role of tumour promotion in chemical carcinogenesis.
Boutwell RK
IARC Sci Publ; 1984; (56):3-11. PubMed ID: 6443106
[No Abstract] [Full Text] [Related]
34. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas.
Reddy AL; Caldwell M; Fialkow PJ
Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053
[TBL] [Abstract][Full Text] [Related]
35. Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation.
Yamamoto H; Ochiya T; Takeshita F; Toriyama-Baba H; Hirai K; Sasaki H; Sasaki H; Sakamoto H; Yoshida T; Saito I; Terada M
Cancer Res; 2002 Mar; 62(6):1641-7. PubMed ID: 11912134
[TBL] [Abstract][Full Text] [Related]
36. Oncogenes and human cancer: cause or consequence?
Barbacid M
Carcinogenesis; 1986 Jul; 7(7):1037-42. PubMed ID: 3087641
[No Abstract] [Full Text] [Related]
37. Molecular alterations in oncogenes or tumor suppressor genes during chemical carcinogenesis.
Burns PA; Brown K; Bremner R; Clarke M; Balmain A
Prog Histochem Cytochem; 1991; 23(1-4):100-6. PubMed ID: 1947131
[No Abstract] [Full Text] [Related]
38. Chalones revisited--a possible role for transforming growth factor beta in tumour promotion.
Parkinson K; Balmain A
Carcinogenesis; 1990 Feb; 11(2):195-8. PubMed ID: 2137380
[No Abstract] [Full Text] [Related]
39. Oncogene mechanism suggests novel therapeutic approaches to cancer.
Newman PA
J Natl Cancer Inst; 1990 Sep; 82(17):1383-4. PubMed ID: 2201782
[No Abstract] [Full Text] [Related]
40. Transforming genes: oncogenes, genes, and growth factors.
Ihle JN
Science; 1987 Aug; 237(4818):1060-1. PubMed ID: 17837399
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
